Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve technology for the treatment of Tricuspid Regurgitation as part of its TANDEM I study in Poland.
News | Heart Valve Technology
CroíValve Reports Successful First in Human Implants of its DUO Tricuspid Coaptation Valve System

November 22, 2022 — CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve ...

Home November 22, 2022
Home
UH Cleveland Medical Center. Image courtesy of University Hospitals
News | Deep Vein Thrombosis (DVT)
Four Prospective, Multicenter Studies Support Use of Drug-Coated Balloons Over Bare Metal Stents in Treating Femoropopliteal Lesions

November 21, 2022 —  New research published in the Journal of the American College of Cardiology shows the use of drug ...

Home November 21, 2022
Home
Reduction in the risk of death or major bleeding after primary PCI in patients with STEMI treated with heparin monotherapy (blue curve) or bivalirudin with a post-procedure infusion (red curve). The hazard ratio of 0.69 signifies a 31% reduction in risk. The ARR (absolute risk reduction) was 1.3%. The NNT (number of patients needed to treat to prevent one death or large bleed) was 76. Image courtesy of Mount Sinai Health System
News | Antiplatelet and Anticoagulation Therapies
Bivalirudin Found to be Safer and More Effective Than Heparin for Treating Heart Attack Patients Undergoing Percutaneous Coronary Intervention

November 14, 2022 — Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the ...

Home November 14, 2022
Home
Cryoablation involves guiding a small tube into the heart and inflating a small balloon to kill problematic tissue with cold temperatures. Image courtesy of Medtronic
News | Atrial Fibrillation
National Study Suggests It's Time to Rethink How We Treat Atrial Fibrillation

November 10, 2022 —  A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding ...

Home November 10, 2022
Home
Feature | Angiography | By Bhvita Jani
Interventional X-ray and Mobile C-arm Equipment Markets Had a Double-digit Recovery in 2021

The world market for interventional X-ray and mobile C-arm equipment is forecast to reach over $4.9 billion by 2026 ...

Home November 09, 2022
Home
Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more accurate non-invasive diagnosis, fewer unnecessary tests, and higher confidence in identifying patients needing treatment
News | AHA
Late-Breaking Data Demonstrate AHA/ACC Guideline-Directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing

November 7, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heartcare, today announced new trial results ...

Home November 07, 2022
Home
Study Advances Efforts to Launch CARDIALYTICS Suite of Analytic Tools
News | EP Lab
CathVision Announces Initiation of Clinical Study Evaluating Signal Complexity Algorithm

Nov. 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance ...

Home November 05, 2022
Home
Late-breaking clinical presentations at VIVA show IN.PACT Admiral drug-coated PTA balloon catheter outperforms bare metal stents; maintains performance in real-world setting
News | VIVA
Clinical Studies Show Medtronic Drug Coated Balloon Outperforms Bare Metal Stents; Maintains Performance in Real World

November 3, 2022 — Medtronic, a global leader in medical technology, today announced the results of two clinical studies ...

Home November 03, 2022
Home
News | VIVA
VIVA Foundation Symposium presents Clinical Trial Findings

November 2, 2022 — The second round of late-breaking clinical trial results were announced at VIVA22 on Nov. 1 in Las ...

Home November 02, 2022
Home
News | VIVA
The VEINS/VIVA 2022 Top Awards Recognize Leaders in Vascular Medicine

November 2, 2022 — A number of awards of distinction were presented during The VEINS (Venous Endovascular INterventional ...

Home November 02, 2022
Home
Deepak L. Bhatt, MD, MPH
News | Cardiovascular Business
Deepak L. Bhatt, MD, MPH, Named Director of Mount Sinai Heart

November 1, 2022 — Deepak L. Bhatt, MD, MPH, a top expert in cardiovascular medicine and interventional cardiology, has ...

Home November 01, 2022
Home
Impella RP Flex with SmartAssist Illustration (Photo: Business Wire)
News | Hemodynamic Support Devices
Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure

November 1, 2022 —  Abiomed announced that Impella RP Flex with SmartAssist has received U.S. Food and Drug ...

Home November 01, 2022
Home
Johnson & Johnson to Acquire Abiomed
Feature | Cardiovascular Business
Johnson & Johnson to Acquire Abiomed

November 1, 2022 — Johnson & Johnson and Abiomed, a world leader in breakthrough heart, lung and kidney support ...

Home November 01, 2022
Home
News | VIVA
Clinical Trials on Venous Care presented at THE VEINS 2022

October 31, 2022 — Results from the Late-Breaking Clinical Trials session at The VEINS Conference in Las Vegas, NV, were ...

Home October 31, 2022
Home
The RELIEVE-HF trial of the Ventura Shunt System includes patients with reduced and preserved left ventricular function etiologies for heart failure
News | Heart Failure
V-Wave Completes Enrollment in the RELIEVE-HF Randomized Double-Blind Controlled Trial of Interatrial Shunting for Heart Failure

October 28, 2022 —  V-Wave, announced today the completion of enrollment in RELIEVE-HF, a prospective, randomized ...

Home October 28, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now